Cerenome, Inc. (CNSY) vs Pulmatrix, Inc. (PULM)

Cerenome, Inc. and Pulmatrix, Inc. are both Biotechnology companies. Cerenome, Inc. and Pulmatrix, Inc. are of similar size ($5.1M and $5.1M). Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against −21.0%. Pulmatrix, Inc. has the higher net margin (0.00% vs −620.7%) and the higher return on invested capital (0.00% vs −532.8%). Across the 16 metrics below, Pulmatrix, Inc. leads on 14 and Cerenome, Inc. on 2.

Valuation

Metric CNSY PULM Biotechnology median
P/E n/m n/m 10.60
P/S 1.05 0.65 9.40
P/B 0.81 3.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.55 0.84 9.02
Earnings yield (682.81%) (79.14%) (32.88%)
Free cash flow yield (545.84%) (84.87%) (23.13%)

Profitability

Metric CNSY PULM Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (628.12%) 0.00% 0.00%
Net margin (620.70%) 0.00% 0.00%
Free cash flow margin (560.29%) 0.00% 0.00%
Return on equity (614.05%) (111.99%) (51.96%)
Return on assets (214.01%) (85.74%) (46.06%)
Return on invested capital (532.77%) 0.00% 0.00%

Growth

Metric CNSY PULM Biotechnology median
Revenue growth (TTM) (20.95%) 6.96% 6.76%
EPS growth (last fiscal year) 82.79% 46.18% 29.88%
Revenue growth, 5-year CAGR (5.72%) (0.26%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSY PULM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.37 4.70 4.97
Net debt to EBITDA 0.83 0.79 1.01

Dividend

Metric CNSY PULM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNSY PULM Biotechnology median
Market cap 5.09m 5.11m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack